Skip to content

Clinical trials

Phase 2 Diabetic Neuropathies trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Neuropathies Phase: Phase 2 Country / region: United States Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20065
20075
20085
20094
20101
20111
20123
20133
20143
20151
20161
20171
20181
20192
20202
20223
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Terminated6
Unknown status3
Withdrawn2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sangamo Therapeutics4
BioDelivery Sciences International3
Pfizer3
AbbVie (prior sponsor, Abbott)2
AstraZeneca2
James P. Rathmell, MD2
Takeda2
Allergan1
Arcion Therapeutics Inc1
Beth Israel Deaconess Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Neuropathies47
Diabetes Mellitus15
Pain13
Neuralgia11
Diabetes Mellitus, Type 14
Diabetes Mellitus, Type 24
Agnosia3
Chronic Pain3
Diabetes Complications3
Diabetic Foot2

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.